UPDATE
2-Drugmaker Shire bids $30 bln for
Baxter spin-off Baxalta
LONDON, Aug 4 (Reuters) - Drugmaker
Shire said on Tuesday it was seeking to buy Baxalta, a company spun-off by
Baxter International last month, for $30 billion to forge the leading global specialist...
